Who owns IMMUNOPRECISE ANTIBODIES LTD COM NEW?

Tip: Access positions for across all investors

Analyze quarterly positions in Immunoprecise Antibodies with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Immunoprecise Antibodies stock

Who bought or sold IMMUNOPRECISE ANTIBODIES LTD COM NEW this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Ingalls & Snyder 1.3M $2.2M 25% Dec 2023
 View chart
Citadel Advisors 302k $517k 25% Dec 2023
 View chart
Susquehanna International 99k $181k -19% Sep 2023
 View chart
Squarepoint Ops 48k $82k 100% Dec 2023
 View chart
Bank Of Montreal 48k $83k -74% Dec 2023
 View chart
CIBC World Markets 42k $76k -2% Sep 2023
 View chart
Gradient Capital Advisors 27k $46k 0% Dec 2023
 View chart
Millennium Management 19k $33k 100% Dec 2023
 View chart
Geode Capital Management 18k $32k 0% Sep 2023
 View chart
Renaissance Technologies 15k $27k 100% Sep 2023
 View chart
Rathbones Brothers 14k $26k 100% Sep 2023
 View chart
Dimensional Fund Advisors 12k $21k -23% Dec 2023
 View chart
UBS Group 11k $18k 15157% Dec 2023
 View chart
Mariner Wealth Advisors 10k $17k 100% Dec 2023
 View chart
Royal Bank of Canada 3.1k $5.0k 0% Dec 2023
 View chart
Simplex Trading 2.7k $4.0k 23% Dec 2023
 View chart
Group One Trading 2.4k $4.4k 51% Sep 2023
 View chart
West Paces Advisors 1.7k $2.8k 0% Dec 2023
 View chart
National Bank Of Canada /fi/ 1.5k $2.5k 0% Dec 2023
 View chart
Morgan Stanley 533.00 $975.016900 0% Sep 2023
 View chart
TD Waterhouse Canada 200.00 $420.000000 0% Dec 2023
 View chart
Cutler 60.00 $0 0% Dec 2023
 View chart
Citigroup 7.00 $12.000100 0% Dec 2023
 View chart

Who sold out of Immunoprecise Antibodies?

Fund or Company Name Date Sold Shares Held Valued At
Tower Research Capital Jun 2023 7.6k $22k